BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death

<div>Summary of S100A8 and S100A9 microarray analysis. OCI-AML3 cell lines were treated with 0.5<i>μ</i>M JQ1 for 16hr.</div>

Bone Marrow Research

fig1

Figure 1

Figure 1: BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death 

Figure 1 | BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death 